Pharmadrug Inc.

Pharmadrug Inc.

PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

Unlocking the potential of psychedelics, including DMT, and other tryptamines to treat the significant unmet medical needs of glaucoma patientsPartnering with world-renowned research institution brings validated drug delivery expertise in novel, controlled drug-release technologiesToronto, Ontario--(Newsfile Corp. - August 5, 2021) - Phar... Read More...

PharmaDrug Signs Supply Agreement with European Cannabis Extractor for Medical Grade THC Oil to Be Sold Under PharmaDrug Brand

Toronto, Ontario--(Newsfile Corp. - May 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, ... Read More...

Pharmadrug Provides Corporate Update and Balance Sheet Status

Toronto, Ontario--(Newsfile Corp. - December 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to provide an update to the status of its balance sheet following the recent general equity market upswing and the increase in PharmaDrug's volume and share price appreciation.Recent market acti... Read More...

Pharmadrug Shortlists Prime Amsterdam Locations for State-of-the-art Smart Shop Superstore and Expands Scope of E-Commerce Platform with Essential Good

Toronto, Ontario--(Newsfile Corp. - November 30, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") will be launching its new Slim Winkel brand in the next couple of weeks. The Company's wo... Read More...

PharmaDrug Positions for Eurozone Psychedelic Distribution as Germany Begins Psilocybin Depression Study

Toronto, Ontario--(Newsfile Corp. - November 23, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") applauds the recent approval by Germany's Federal Institute of Drugs and Medical Devices (BfArM) of a study examining the Efficacy and Safety of Psilocybin in Treatment-Resistant Depression. This marks the... Read More...

Dillard’s, Inc. Reports Third Quarter Results

Dillard’s, Inc. (NYSE: DDS) (the "Company" or "Dillard’s") announced operating results for the 13 and 39 weeks ended October 31, 2020. This release contains certain forward-looking statements. Please refer to the Company’s cautionary statements included below under "Forward-Looking Information." In particular, these results include certai... Read More...

PharmaDrug’s Super Smart Begins to Work with Essential Good to Develop Its Brand and Build an Innovative Online Retail Platform

Toronto, Ontario--(Newsfile Corp. - October 13, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has begun to work with Essential Good LLC ("Essential Good") to develop its Slim Wink... Read More...

PharmaDrug’s Super Smart Reaches Distribution Agreement with Red Light Holland for iMicrodose Packs and for Red Light Holland to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart’s Location in Tiel, The Netherlands

Toronto, Ontario--(Newsfile Corp. - September 28, 2020) -  PharmaDrug Inc. (CSE: BUZZ) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has reached a distribution agreement with Red Light Holland Corp. (CSE: TRIP) (FSE... Read More...

PharmaDrug Inc. Closes Transaction to Acquire First Smart Shop in the Netherlands and Now Initiates Major Push to Acquire Best of Breed High Traffic Locations

Toronto, Ontario--(Newsfile Corp. - September 21, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has closed the transaction to acquire the retail establishment specializing in the sale ... Read More...

PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands

Toronto, Ontario--(Newsfile Corp. - August 11, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has entered into a definitive agreement to acquire (the "Acquisition") a retail establ... Read More...

PharmaDrug Inc. Repays Amounts Owing Under Bridge Loan and Advisory Agreement, Completes Previously Announced Debt Restructuring and Provides Financial Update

Toronto, Ontario--(Newsfile Corp. - July 17, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has repaid amounts owing by the Company to the lender (inclusive of interest and fees) pursuant to a bridge loan (the "Bridge Loan") and amounts owing to a financial advisor under an ... Read More...

Pharmadrug Inc. Provides Update on Debt Restructuring

Toronto, Ontario--(Newsfile Corp. - July 9, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug") is pleased to announce that further to its press release dated May 20, 2020, that it proposes to complete a restructuring of certain of its outstanding indebtedness.Under the terms of the restructuring the outstanding $400,000 ... Read More...

Pharmadrug Inc. Completes Acquisition of Super Smart with a New Added Focus on the Psychedelic Market

Toronto, Ontario--(Newsfile Corp. - June 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has completed its previously announced (see press release dated May 25, 2020) acquisition of all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing business as Super Smart)... Read More...

Pharmadrug Inc. Enters into Unsecured Promissory Note

Toronto, Ontario--(Newsfile Corp. - May 25, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") announced today that it has issued a non-interest bearing unsecured promissory note to privately-held Interrobang Ltd. (doing business as Super Smart) ("Super Smart") pursuant to which Super Smart will loan the Company $80,000 payab... Read More...

Pharmadrug Inc. Enters Definitive Agreement to Acquire Super Smart Paving Its Entry into the Psychedelic Market

Toronto, Ontario--(Newsfile Corp. - May 25, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has entered into a definitive agreement (the "Acquisition Agreement") pursuant to which Pharmadrug will acquire all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing busine... Read More...

Pharmadrug Inc. Plans to Enter the Psychedelic Space with An LOI To Acquire Super Smart and Provides Business Update

Toronto, Ontario--(Newsfile Corp. - May 20, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent") dated May 20, 2020 with Interrobang Ltd. doing business as Super Smart (herein referred to as "Super Smart") which outlines the ... Read More...

Pharmadrug Inc. Provides Update on COVID-19 and Announces Request for Extension of Filing Financial Statements as Well as Positive Business and Corporate Updates

Toronto, Ontario--(Newsfile Corp. - April 24, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company") is providing an update on COVID-19 matters and an update on the status of filing its financial statements and accompanying management's discussion and analysis, and related CEO and CFO certifications for the financial year ended ... Read More...

Pharmadrug Announces Q3 2019 Financial Results

Toronto, Ontario--(Newsfile Corp. - November 29, 2019) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "Pharmadrug"), a leading European medical cannabis distribution company, today announced its financial results for the third quarter ending September 30, 2019. The Company's full Management's Discussion and Analysis ("MD&... Read More...

Israeli Government in Discussions on Medical Cannabis Export Framework & Appointment of New Board Member

Toronto, Ontario--(Newsfile Corp. - November 19, 2019) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "Pharmadrug") would like to update investors on developments from Israel's Ministry of Health regarding the export law on medical cannabis passed in January of 2019 (the "Export Law"). It was revealed late last week that the... Read More...

Pharmadrug Signs Major Canadian Supply Agreement with Canada House Wellness for German Distribution as German Governing Party Moves Closer to Recreational Cannabis Legislation

Toronto, Ontario--(Newsfile Corp. - October 31, 2019) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "Pharmadrug") is pleased to announce a multi-year supply agreement (the "Supply Agreement") between 80% owned subsidiary Pharmadrug Production GmbH and Canada House Wellness Group Inc. (CSE: CHV) (the "Grower" or "Canada Hous... Read More...

Aura’s Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution

Toronto, Ontario--(Newsfile Corp. - September 19, 2019) - Aura Health Inc. (CSE:BUZZ) (OTC:LMLLF) (the "Company" or "Aura") is pleased to announce a multi-year supply agreement (the "Supply Agreement") between 80% owned subsidiary Pharmadrug Production GmbH ("Pharmadrug") and Israel-based My Green Fields Ltd. ("My Green Fields" or the "Gr... Read More...